← Back to Conditions

GM3 synthase deficiency

disorder
SNOMED 722762005CUI C1836824

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Central hypotonia
Always present (100%)HP:0001252
Developmental stagnation at onset of seizures
Always present (100%)HP:0006834
Generalised brain degeneration
Always present (100%)HP:0002283
Generalized tonic-clonic seizure (without specification of onset)
Always present (100%)HP:0002069
Hyporeflexia of upper limbs
Always present (100%)HP:0012391
Irritability
Always present (100%)HP:0000737
Multifocal EEG abnormality
Always present (100%)HP:0010841
Neurodevelopmental regression
Always present (100%)HP:0002376
Psychomotor development deficiency
Always present (100%)HP:0001263
Undergrowth
Always present (100%)HP:0001508
Vomiting
Always present (100%)HP:0002013
Feeding difficulties in infancy
Frequent (30-79%)HP:0008872
Decreased size of cranium
Occasional (5-29%)HP:0000252
Hypoacusis
Occasional (5-29%)HP:0000365
Choreoathetoid movements
HP:0001266
Cortical blindness
HP:0100704
Hyperpigmented macules
HP:0001034
Jerking
HP:0001336
Lower limb hyperreflexia
HP:0002395
No speech development
HP:0001344
Optic atrophy
HP:0000648
Prolonged seizure
HP:0002133
Visual loss
HP:0000572

Quick Facts

SNOMED CT
722762005
UMLS CUI
C1836824
Fully Specified Name
Ganglioside GM3 synthase deficiency (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
23
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.